Access to treatment with Zaponex is controlled by ZTAS  which is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). ZTAS is managed by a team of fully trained staff who are also able to provide support and guidance on patient-specific enquiries. At ZTAS, we are also able to provide our customers with on-going, locally based training on the ZTAS system as well as a wide range of fact sheets and support materials.